Dhillon is an instructor in the Division of Global Health Equity at Brigham and Women’s Hospital and Harvard Medical School.

MedStar executive Raj Ratwani says the idea of shared responsibility should be central to how health AI is regulated.

A dispute over a Duchenne gene therapy highlights thorny issues surrounding FDA approvals and insurance policies.

Cobenfy was approved to reduce the psychotic symptoms associated with schizophrenia. It is a new type of medicine that works ...

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

Pfizer’s decision Wednesday to pull its sickle cell pill off the market because of safety concerns shocked advocates and ...

Biden administration officials have abandoned their own proposal to require drug companies to disclose the prices and ...

On STAT's Readout LOUD podcast, Jonathan Wosen talks about Genentech shutting down its cancer immunology team, and the ...

Sen. Maggie Hassan of New Hampshire is the lead Democrat in the Senate pushing to equalize payments between hospitals and ...

Particle Health's antitrust lawsuit is a direct threat to Epic Systems' dominance in the multi-billion dollar market for ...

Medicare’s controversial decision to condition coverage for even fully approved Alzheimer’s drugs is here to stay, per a top ...

After years of pressure, the FDA said it is strengthening its review of many chemical additives used to enhance color, ...